←back to thread

279 points bookofjoe | 1 comments | | HN request time: 0s | source
Show context
siliconc0w ◴[] No.44609926[source]
Sadly health insurance in the US is unlikely to pay for most preventative care because the followup costs of false-positives and that they are betting that down the line someone else will pick up the tab when you get sick decades later (like the government).

It's kind of why I'm favor of universal option to align financial incentives. Like given how sick the US population is, it probably makes sense to put a lot more people of GPL-1s and invest in improving their efficacy and permanence. Like nationalize-the-patent COVID-operational-warp-speed level urgency. There are over 100M Americans that are pre-diabetic, the cost of treating a diabetic is about 20k/yr. So $4 trillion in new costs, on top of the misery and human suffering.

replies(6): >>44610089 #>>44610202 #>>44610203 #>>44610287 #>>44612299 #>>44613546 #
riscy ◴[] No.44610202[source]
How do you convince those pre-diabetic people to use a GLP-1? There was quite a bit of backlash about the one-time injection COVID vaccine when it was mandated.
replies(2): >>44610473 #>>44611129 #
1. lispisok ◴[] No.44610473[source]
Are you expecting the government to mandate GLP-1 agonists the same way they tried to mandate the covid shot?